These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 6452198
1. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells. Ayusawa D, Koyama H, Seno T. Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198 [Abstract] [Full Text] [Related]
2. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Moran RG, Mulkins M, Heidelberger C. Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5924-8. PubMed ID: 160558 [Abstract] [Full Text] [Related]
9. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors. Balzarini J, de Clercq E, Ayusawa D, Seno T. FEBS Lett; 1984 Jul 23; 173(1):227-32. PubMed ID: 6745430 [Abstract] [Full Text] [Related]
14. Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase. Ayusawa D, Koyama H, Iwata K, Seno T. Somatic Cell Genet; 1980 Mar 23; 6(2):261-70. PubMed ID: 6994265 [Abstract] [Full Text] [Related]
15. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine. Zhang ZG, Malmberg M, Yin MB, Slocum HK, Rustum YM. Biochem Pharmacol; 1993 Mar 09; 45(5):1157-64. PubMed ID: 8461045 [Abstract] [Full Text] [Related]
16. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells. Jastreboff MM, Kedzierska B, Rode W. Biochem Pharmacol; 1983 Jul 15; 32(14):2259-67. PubMed ID: 6223641 [Abstract] [Full Text] [Related]